| Overview |
| bsm-61716r-fitc-100ul |
| IGFBP2 Recombinant Antibody, FITC Conjugated |
| WB, IF |
| Human |
| Specifications |
| FITC |
| Rabbit |
| KLH conjugated synthetic peptide derived from human IGFBP2 |
| Recombinant |
| IgG |
| Lot dependent |
| Purified by Protein A. |
| Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
| Target |
| 3485 |
| P18065 |
| Secreted |
| BP2; IBP2; IGF BP53; IGFBP2; IGFBP53. |
| Inhibits IGF-mediated growth and developmental rates. IGF-binding proteins prolong the half-life of the IGFs and have been shown to either inhibit or stimulate the growth promoting effects of the IGFs on cell culture. They alter the interaction of IGFs with their cell surface receptors. |
| Application Dilution |
| WB |
1:300-5000 |
| IF |
|
Powered by Bioz